Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin)

Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells

Murphy, L. C.
Peng, B.
Lewis, A.
Davie, J. R.
Leygue, E.
Kemp, A.
Ung, K.
Vendetti, M.
Shiu, R.

January 2005

This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...

A role for insulin-like growth factor binding protein 5 in the antiproliferative action of the antiestrogen ICI 182780

Huynh, H.
Yang, X. F.
Pollak, M.

November 1996

1. The journal Cell Growth and Differentiation is the original source of the material.2. This articl...

Inhibition of IGF1R activity enhances response to trastuzumab in HER-2 positive breast cancer cells

Browne, BC
Crown, J
Venkatesan, N
Duffy, MJ
Clynes, M
Slamon, D
O'Donovan, N
Jeay, Sebastien

July 2010

BACKGROUND: Although trastuzumab has improved the prognosis for HER-2 positive breast cancer, not al...

Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin)

Lu, Y.
Zi, X.
Zhao, Y.
Mascarenhas, D.
Pollak, M.

December 2001

This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...

EDITORIALS Unraveling Resistance to Trastuzumab (Herceptin): Insulin-Like Growth Factor-I Receptor, a New Suspect

Joan Albanell
Jose Baselga

January 2015

Trastuzumab (Herceptin) is a humanized antibody directed against the extracellular domain of the tyr...

Regulation of insulin-like growth factor I receptor expression by the pure antiestrogen ICI 182780

Huynh, H.
Nickerson, T.
Pollak, M.
Yang, X.

December 1996

1. The journal Clinical Cancer Research is the original source of the material2. This article is hos...

Insulin-like growth factor binding proteins 1 and 3 and breast cancer outcomes

Goodwin, P. J.
Ennis, M.
Pritchard, K. I.
Trudeau, M. E.
Koo, J.
Hartwick, W.
Hoffma, B.
Hood, N.

January 2002

This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...

Insulin-like growth factor 1 (IGF-1) receptors, IGF-1, and IGF-2 are expressed in primary human sarcomas

Sekyi-Otu, A.
Bell, R. S.
Ohashi, C.
Pollak, M.
Andrulis, I. L.

January 1995

1. The journal Cancer Research is the original source of the material.2. This article is hosted on a...

Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycin

Nielsen, T.O.
Andrews, H.N.
Cheang, M.
Kucab, J.E.
Hsu, F.D.
Ragaz, J.
Gilks, C.B.
Makretsov, N.
Bajdik, C.D.
Brookes, C.
Neckers, L.M.
Evdokimova, V.
Huntsman, D.G.
Dunn, S.E.

January 2004

1. The journal Cancer Research is the original source of the material.2. This article is hosted on a...

Microarray analysis and identification of novel molecules involved in insulin-like growth factor-1 receptor signaling and gene expression

Dupont, J.
Dunn, S. E.
Barrett, J. C.
LeRoith, D.

January 2003

This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...

REPORTS Insulin-Like Growth Factor-I Receptor Signaling and Resistance to Trastuzumab (Herceptin)

Yuhong Lu
Xiaolin Zi
Zhao Desmond Mascarenhas
Michael Pollak

March 2015

tin), an anti-HER2/neu receptor mono-clonal antibody that inhibits growth of ErbB2-overexpressing br...

Insulin-like growth factor-1 inscribes a gene expression profile for angiogenic factors and cancer progression in breast epithelial cells

Oh, J.S.
Kucab, J.E.
Bushel, P.R.
Martin, K.
Bennett, L.
Collins, J.
DiAugustine, R.P.
Barrett, J.C.
Afshari, C.A.
Dunn, S.E.

January 2002

This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...

Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780

Chan, T. W.
Pollak, M.
Huynh, H.

August 2001

1. The journal Clinical Cancer Research is the original source of the material.2. This article is ho...

ETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylation

Morrison, K. B.
Tognon, C. E.
Garnett, M. J.
Deal, C.
Sorensen, P. H.

January 2002

This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...

Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density

Byrne, C.
Colditz, G. A.
Willett, W. C.
Speizer, F. E.
Pollak, M.
Hankinson, S. E.

July 2000

1. The journal Cancer Research is the original source of the material.2. This article is hosted on a...

Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells

Murphy, L. C.
Peng, B.
Lewis, A.
Davie, J. R.
Leygue, E.
Kemp, A.
Ung, K.
Vendetti, M.
Shiu, R.

January 2005

This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...

A role for insulin-like growth factor binding protein 5 in the antiproliferative action of the antiestrogen ICI 182780

Huynh, H.
Yang, X. F.
Pollak, M.

November 1996

1. The journal Cell Growth and Differentiation is the original source of the material.2. This articl...

Inhibition of IGF1R activity enhances response to trastuzumab in HER-2 positive breast cancer cells

Browne, BC
Crown, J
Venkatesan, N
Duffy, MJ
Clynes, M
Slamon, D
O'Donovan, N
Jeay, Sebastien

July 2010

BACKGROUND: Although trastuzumab has improved the prognosis for HER-2 positive breast cancer, not al...

Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin)

Lu, Y.
Zi, X.
Zhao, Y.
Mascarenhas, D.
Pollak, M.

December 2001

This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...

EDITORIALS Unraveling Resistance to Trastuzumab (Herceptin): Insulin-Like Growth Factor-I Receptor, a New Suspect

Joan Albanell
Jose Baselga

January 2015

Trastuzumab (Herceptin) is a humanized antibody directed against the extracellular domain of the tyr...

Regulation of insulin-like growth factor I receptor expression by the pure antiestrogen ICI 182780

Huynh, H.
Nickerson, T.
Pollak, M.
Yang, X.

December 1996

1. The journal Clinical Cancer Research is the original source of the material2. This article is hos...

Insulin-like growth factor binding proteins 1 and 3 and breast cancer outcomes

Goodwin, P. J.
Ennis, M.
Pritchard, K. I.
Trudeau, M. E.
Koo, J.
Hartwick, W.
Hoffma, B.
Hood, N.

January 2002

This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...

Insulin-like growth factor 1 (IGF-1) receptors, IGF-1, and IGF-2 are expressed in primary human sarcomas

Sekyi-Otu, A.
Bell, R. S.
Ohashi, C.
Pollak, M.
Andrulis, I. L.

January 1995

1. The journal Cancer Research is the original source of the material.2. This article is hosted on a...

Expression of the insulin-like growth factor I receptor and urokinase plasminogen activator in breast cancer is associated with poor survival: potential for intervention with 17-allylamino geldanamycin

Nielsen, T.O.
Andrews, H.N.
Cheang, M.
Kucab, J.E.
Hsu, F.D.
Ragaz, J.
Gilks, C.B.
Makretsov, N.
Bajdik, C.D.
Brookes, C.
Neckers, L.M.
Evdokimova, V.
Huntsman, D.G.
Dunn, S.E.

January 2004

1. The journal Cancer Research is the original source of the material.2. This article is hosted on a...

Microarray analysis and identification of novel molecules involved in insulin-like growth factor-1 receptor signaling and gene expression

Dupont, J.
Dunn, S. E.
Barrett, J. C.
LeRoith, D.

January 2003

This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...

REPORTS Insulin-Like Growth Factor-I Receptor Signaling and Resistance to Trastuzumab (Herceptin)

Yuhong Lu
Xiaolin Zi
Zhao Desmond Mascarenhas
Michael Pollak

March 2015

tin), an anti-HER2/neu receptor mono-clonal antibody that inhibits growth of ErbB2-overexpressing br...

Insulin-like growth factor-1 inscribes a gene expression profile for angiogenic factors and cancer progression in breast epithelial cells

Oh, J.S.
Kucab, J.E.
Bushel, P.R.
Martin, K.
Bennett, L.
Collins, J.
DiAugustine, R.P.
Barrett, J.C.
Afshari, C.A.
Dunn, S.E.

January 2002

This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...

Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780

Chan, T. W.
Pollak, M.
Huynh, H.

August 2001

1. The journal Clinical Cancer Research is the original source of the material.2. This article is ho...

ETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylation

Morrison, K. B.
Tognon, C. E.
Garnett, M. J.
Deal, C.
Sorensen, P. H.

January 2002

This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...

Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density

Byrne, C.
Colditz, G. A.
Willett, W. C.
Speizer, F. E.
Pollak, M.
Hankinson, S. E.

July 2000

1. The journal Cancer Research is the original source of the material.2. This article is hosted on a...

Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells

Murphy, L. C.
Peng, B.
Lewis, A.
Davie, J. R.
Leygue, E.
Kemp, A.
Ung, K.
Vendetti, M.
Shiu, R.

January 2005

This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...

A role for insulin-like growth factor binding protein 5 in the antiproliferative action of the antiestrogen ICI 182780

Huynh, H.
Yang, X. F.
Pollak, M.

November 1996

1. The journal Cell Growth and Differentiation is the original source of the material.2. This articl...

Inhibition of IGF1R activity enhances response to trastuzumab in HER-2 positive breast cancer cells

Browne, BC
Crown, J
Venkatesan, N
Duffy, MJ
Clynes, M
Slamon, D
O'Donovan, N
Jeay, Sebastien

July 2010

BACKGROUND: Although trastuzumab has improved the prognosis for HER-2 positive breast cancer, not al...

Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin)

Abstract

Extracted data

Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin)

Abstract

Extracted data

Related items

Related items